This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,640.32 contract is for the supply of STELARA 90 MG/ML SYRINGE to support the medical needs of the Department of Defense. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC covers a broad range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain. This particular delivery order does not have a set-aside designation.
Generated 3/5/25, 10:02 AM